Literature DB >> 10222655

Multiple myeloma preceding the development of chronic myelogenous leukemia.

M Nitta1, K Tsuboi, S Yamashita, M Kato, Y Hayami, S Harada, H Komatsu, S Iida, S Banno, A Wakita, R Ueda.   

Abstract

A case of a 70-year-old man who first developed multiple myeloma and then chronic myelogenous leukemia (CML) within a 3-year period is documented. The patient, with monoclonal hypergammopathy, was diagnosed with smoldering myeloma with IgG-kappa and Bence Jones protein kappa paraproteinemia. No chemotherapy was given for the myeloma until progressive leukocytosis developed after approximately 3 years. This was found to be due to Philadelphia chromosome positive CML. A reverse transcription-polymerase chain reaction assay did not reveal BCR/ABL mRNAs when the myeloma was first diagnosed. The occurrence of 2 distinct hematologic malignancies in the same patient suggests either a different clonal evolution from a common pluripotent malignant stem cell since the CML stem cell also involves the B-lymphoid lineage, a coincident complication of the 2 hematological malignancies, or the coexistence of 2 distinct malignancies due to the same genetic background and/or exposure to similar carcinogenic agents. The literature provides support for the existence of a relationship between multiple myelomas and CML.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10222655

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  9 in total

1.  Co-existing chronic myeloid leukaemia and multiple myeloma: rapid response to lenalidomide during imatinib treatment.

Authors:  C Offiah; J P Quinn; P Thornton; P T Murphy
Journal:  Int J Hematol       Date:  2012-03-17       Impact factor: 2.490

Review 2.  Uncommon case of chronic myeloid leukemia with multiple myeloma.

Authors:  Masaru Ide; Nobuo Kuwahara; Eijo Matsuishi; Shinya Kimura; Hisashi Gondo
Journal:  Int J Hematol       Date:  2010-03-30       Impact factor: 2.490

3.  Reply to MacLeod et al.: Multiple myeloma plasma cells have chameleon characteristics.

Authors:  Susanne B Breitkopf; Min Yuan; German A Pihan; John M Asara
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-22       Impact factor: 11.205

4.  An asymptomatic 61-year-old man with BCR-ABL-positive bone marrow following autologous transplantation for multiple myeloma.

Authors:  Nitin Roper; Daniel J DeAngelo; Frank Kuo; Paola Dal Cin; Irene Ghobrial; Jon C Aster
Journal:  Am J Hematol       Date:  2010-12       Impact factor: 10.047

5.  Coexistence of chronic myeloid leukemia and pulmonary plasmacytoma mimicking primary lung cancer.

Authors:  Hee Jin Kim; Moon Jin Kim; Min Jeong Lee; Jong-Hwa Ahn; Ho-Su Kim; In-Suk Kim; Jong Sil Lee; Gyeong-Won Lee
Journal:  Int J Hematol       Date:  2010-10-22       Impact factor: 2.490

6.  A case of multiple myeloma with metachronous chronic myeloid leukemia treated successfully with bortezomib, dexamethasone, and dasatinib.

Authors:  Samer Alsidawi; Abhimanyu Ghose; Julianne Qualtieri; Neetu Radhakrishnan
Journal:  Case Rep Oncol Med       Date:  2014-12-02

7.  Unusual case of simultaneous presentation of plasma cell myeloma, chronic myelogenous leukemia, and a jak2 positive myeloproliferative disorder.

Authors:  J Maerki; G Katava; D Siegel; J Silberberg; P K Bhattacharyya
Journal:  Case Rep Hematol       Date:  2014-10-15

8.  An Unprecedented Case of p190 BCR-ABL Chronic Myeloid Leukemia Diagnosed during Treatment for Multiple Myeloma: A Case Report and Review of the Literature.

Authors:  Kosuke Miki; Naoshi Obara; Kenichi Makishima; Tatsuhiro Sakamoto; Manabu Kusakabe; Takayasu Kato; Naoki Kurita; Hidekazu Nishikii; Yasuhisa Yokoyama; Mamiko Sakata-Yanagimoto; Yuichi Hasegawa; Shigeru Chiba
Journal:  Case Rep Hematol       Date:  2018-10-10

9.  Emergence of chronic myeloid leukemia following autologous stem cell transplantation in a young woman with multiple myeloma.

Authors:  Aisling Barrett; Siobhán Glavey; Jeremy Sargent; Patrick Thornton; Philip Murphy; John Quinn
Journal:  Blood Res       Date:  2018-09-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.